Health Plans

Woundtech is a preferred provider for over 50 health plans, 300 medical groups, has over 3.5 million assessments documented to date, and a census of over 3,500 active patients.

Why Woundtech?

Patients currently being treated for wounds that can be referred to Woundtech:
  • By Home Health
  • In an Outpatient Wound Care Center
  • Using negative pressure wound therapy (NPWT or VAC®)
  • Using hyperbaric oxygen therapy (HBOT)
  • By a Podiatrist that has not healed within 30 days
  • In a SNF for pressure injuries, Stage 2 or greater, or any other type of wounds
  • Any patient with a wound(s) not responding to conventional care within 30 days

Woundtech manages wounds with evidenced-based and patient-indicated therapies, largely eliminating high costs. Woundtech’s field clinicians are Podiatrists, Nurse Practitioners and Physician Assistants with the ability to change and write orders at the point of care and they collaborate care with advanced telehealth, predictive analytics, proven formulary, and engaged clinician teams to provide ongoing care monitoring and adjust plans of care on a case-by-case basis.

Using a formulary of more than 125 different advanced high-quality wound care products in 14 categories, Woundtech’s clinician team delivers patient-centric, concierge care wherever patients reside – including ALFs and SNFs.  Using evidence based clinical algorithms configured with Woundtech’s proprietary Sequential Assisted Logic and Clinical Alerts, utilizing machine learning and Artificial Intelligence (AI), Woundtech takes precision wound care to new levels, healing patients faster and lowering costs across the board. This model improves healing rates and helps reduce wound-related hospitalizations; utilization of negative pressure wound therapy, as well as hyperbaric oxygen therapy – significantly improving the overall patient experience.

The key to effectively managing wound care and its resulting expenses is early intervention. Late treatment means astronomically higher costs and, frequently, amputation. Studies show that following an amputation, there is a 50% mortality rate for people with vascular disease and diabetes with a life expectancy from two to five years.  Wound care is a race that patients cannot afford to lose.

By treating patients where they live, Woundtech’s approach eliminates many of the challenges of wound care while ensuring true health equity.

Woundtech provides care that is adjunctive to patients’ PCP. The PCP or primary care provider retains overall management of patient, while Woundtech faxes notes after every visit, ensuring that the care is seamless and cohesive. Woundtech’s goal is to heal patients so they can return to the care of their PCP.

Areas of Service

Woundtech currently provides advanced care in seven states:
  • Puerto Rico
  • Florida
  • Texas
  • Arizona
  • Nevada
  • California
  • Utah

Scheduled expansion:

  • New Jersey
  • New York
  • Pennsylvania
  • Ohio
  • Georgia
  • Louisiana
  • Indiana
  • Washington DC Metro

Healthplan Partners

Woundtech has partnered with the following plans to service patients and lower wound care costs nationwide